DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Paydary K, Akamaloo A, Ahmadipour A. et al.
N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.
J Clin Pharm Ther 2016;
41: 214-219
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.